Triplet therapy including darolutamide should be standard of care in mCSPC, data indicate

Research output: Contribution to journal › Article › peer-review

ASJC Scopus subject areas

@article{e747f398c80c404d949bbfd6c0efe525,

title = "Triplet therapy including darolutamide should be standard of care in mCSPC, data indicate",

author = "Colleen Moretti and Maha Hussain",

year = "2023",

language = "English (US)",

volume = "51",

journal = "Urology Times",

issn = "0093-9722",

publisher = "Urology Times, Inc.",

number = "4",

}

TY - JOUR

T1 - Triplet therapy including darolutamide should be standard of care in mCSPC, data indicate

AU - Moretti, Colleen

AU - Hussain, Maha

PY - 2023

Y1 - 2023

UR - http://www.scopus.com/inward/record.url?scp=85182238178&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85182238178&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:85182238178

SN - 0093-9722

VL - 51

JO - Urology Times

JF - Urology Times

IS - 4

ER -